Pre-market

PME for Tissue and Cell Management System

  • King's College Hospital NHS Foundation Trust
  • London
  • 3 May 2027 to 2 May 2032

End-to-end management and traceability of cellular therapy products from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. Requirements include ISBT 128 labelling, a secure audit trail, quality management of deviations and non-conformances, inventory and storage location management, and reporting. Suppliers must support IQ/OQ/PQ validation before go-live and controlled post-go-live upgrades. Deployment may be on Microsoft-based on-premise infrastructure, supplier-hosted, or cloud/SaaS, and Epic interfaces are of interest.

Due in 4 days· 26 Nov 2026

What
Public sector
Buyer
King's College Hospital NHS Foundation Trust
Estimated value
£375,000
How it will be bought
Not published
Responses due
26 Nov 2026
Contract dates
May 2027 to May 2032

How it will be bought

1 official notice
  1. 11 Nov 2026Planning noticeRead full notice
  2. 26 Nov 2026Responses due
  3. 3 May 2027Contract starts
  4. 2 May 2032Contract ends

King's College Hospital NHS Foundation Trust has awarded 68 contracts in the last 24 months.